In humans, HHcy exacerbates metabolic disturbances, particularly in type 2 diabetes (T2D), where impaired renal clearance of homocysteine and disrupted folate/B12 metabolism further aggravate insulin resistance, β‐cell dysfunction, and microvascular complications (Mursleen and Riaz 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.